# Degowin  Blood Center – FDA Inspection, Apr 16, 2009

Source: https://www.keypedia.com/records/fda_inspections/degowin-blood-center/09ca0779-7b05-40fd-9309-b235a92b8123
Source feed: FDA_Inspections

> FDA inspection 580262 of Degowin  Blood Center, April 16, 2009. Classification: Voluntary Action Indicated (VAI). 2 citations under 21 CFR part 606. 6 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 580262
- Company Name: Degowin  Blood Center
- Inspection Date: 2009-04-16
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Center: Biologics
- Office Name: Center for Biologics Evaluation and Research
- Citation Count: 2

## Related Documents

- FDA Inspection 1259069 - 2024-12-12
- FDA Inspection 1094007 - 2019-06-06
- FDA Inspection 1001567 - 2017-02-15
- FDA Inspection 915232 - 2015-02-13
- [FDA Inspection 805206 - 2012-10-24](https://www.keypedia.com/records/fda_inspections/degowin-blood-center/1acdc010-c60c-4356-862d-468614546190)

Company: https://www.keypedia.com/companies/degowin-blood-center/507368cf-70db-4e35-9d2b-fefd35a9c2aa

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d